LDN Website Update - November 5, 2007

[Guest guest]

LDN Website Update - November 5, 2007

www.low dose naltrexone.org / www.ldninfo.org

Latest News as of October 2007:

Third Annual LDN Conference Sets New Attendance Record

With a full-capacity attendance of 130, the Third Annual Low Dose Naltrexone

Conference

was held on Saturday, October 20th in the Student Life Center of Vanderbilt

University in

Nashville, Tennessee. The conference theme, " Breaking Down Barriers " ,

underscored the

quantum leap in the number of research centers at which trials of LDN have been

implemented within the past year. Please see http://www.ldninfo.org/conf2007.htm

for

further information and conference multimedia. (Please note that video and audio

recordings as well as select slide presentations from the conference should

appear on the

website over the coming weeks.)

Berkson Reports Another Cancer Success for LDN in Journal

Treatment of the patient was reported in the medical journal Integrative Cancer

Therapeutics ( " Reversal of signs and symptoms of a B-cell lymphoma in a patient

using

only low-dose naltrexone, " September 2007, Berkson BM, Rubin DM, and Berkson

AJ). This

is Berkson's second published journal article to describe the successful use of

LDN in a

patient with advanced cancer (see Latest News for April 2006).

(Additional changes/updates have been made to other pages of the website.)

LDN Website Editors

email@...

[Guest guest]

Thanks much . Look forward to reading. david

From:

low dose naltrexone [mailto:low dose naltrexone ] On

Behalf Of Gluck

Sent: Monday, November 05, 2007 4:43 AM

low dose naltrexone

Subject: [low dose naltrexone] LDN Website Update - November 5, 2007

LDN Website Update - November 5, 2007

www.low dose naltrexone.org / www.ldninfo.org

Latest News as of October 2007:

Third Annual LDN Conference Sets New Attendance Record

With a full-capacity attendance of 130, the Third Annual Low Dose Naltrexone

Conference

was held on Saturday, October 20th in the Student Life Center of Vanderbilt

University in

Nashville, Tennessee. The conference theme, " Breaking Down Barriers " ,

underscored the

quantum leap in the number of research centers at which trials of LDN have been

implemented within the past year. Please see http://www.ldninfo.org/conf2007.htm

for

further information and conference multimedia. (Please note that video and

audio

recordings as well as select slide presentations from the conference should

appear on the

website over the coming weeks.)

Berkson Reports Another Cancer Success for LDN in Journal

Treatment of the patient was reported in the medical journal Integrative Cancer

Therapeutics ( " Reversal of signs and symptoms of a B-cell lymphoma in a

patient using

only low-dose naltrexone, " September 2007, Berkson BM, Rubin DM, and

Berkson AJ). This

is Berkson's second published journal article to describe the successful use of

LDN in a

patient with advanced cancer (see Latest News for April 2006).

(Additional changes/updates have been made to other pages of the website.)

LDN Website Editors

email@...

[Guest guest]

Hi

I read the info on LD Naltrexone and it seems to me that there still has to

be more trials done for MS. I gave it to my GP to read and I will be

interested in what he has to say. I'll keep on top of this for more detailed

info. on MS.

Thanks

Z

[low dose naltrexone] LDN Website Update - November 5, 2007

> LDN Website Update - November 5, 2007

> www.low dose naltrexone.org / www.ldninfo.org

>

> Latest News as of October 2007:

>

> Third Annual LDN Conference Sets New Attendance Record

>

> With a full-capacity attendance of 130, the Third Annual Low Dose

> Naltrexone Conference

> was held on Saturday, October 20th in the Student Life Center of

> Vanderbilt University in

> Nashville, Tennessee. The conference theme, " Breaking Down Barriers " ,

> underscored the

> quantum leap in the number of research centers at which trials of LDN have

> been

> implemented within the past year. Please see

> http://www.ldninfo.org/conf2007.htm for

> further information and conference multimedia. (Please note that video and

> audio

> recordings as well as select slide presentations from the conference

> should appear on the

> website over the coming weeks.)

>

> Berkson Reports Another Cancer Success for LDN in Journal

>

> Treatment of the patient was reported in the medical journal Integrative

> Cancer

> Therapeutics ( " Reversal of signs and symptoms of a B-cell lymphoma in a

> patient using

> only low-dose naltrexone, " September 2007, Berkson BM, Rubin DM, and

> Berkson AJ). This

> is Berkson's second published journal article to describe the successful

> use of LDN in a

> patient with advanced cancer (see Latest News for April 2006).

>

> (Additional changes/updates have been made to other pages of the website.)

>

> LDN Website Editors

> email@...

>

>

>

>

>